FDG-PET for Early Response Assessment in Lymphomas PART 1: Hodgkin Lymphoma

被引：0

作者：

Cheson, Bruce D. ^{[1
,2
,3
,4
]}

Kostakoglu, Lale ^{[5
,6
,7
]}

机构：

[1] Georgetown Lombardi Comprehens Canc Ctr, Med, Washington, DC 20523 USA

[2] Georgetown Lombardi Comprehens Canc Ctr, Hematol, Washington, DC 20523 USA

[3] Georgetown Lombardi Comprehens Canc Ctr, Div Hematol Oncol, Washington, DC 20523 USA

[4] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20523 USA

[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[6] Icahn Sch Med Mt Sinai, Nucl Med & Mol Imaging, New York, NY 10029 USA

[7] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA

来源：

ONCOLOGY-NEW YORK | 2017年 / 31卷 / 01期

关键词：

POSITRON-EMISSION-TOMOGRAPHY; INTERIM-PET; PROGNOSTIC VALUE; INTERPRETATION CRITERIA; RADIATION-THERAPY; PREDICT RESPONSE; CELL LYMPHOMA; FREE SURVIVAL; F-18-FDG PET; CYCLES;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Interim positron emission tomography (PET)/CT has shown encouraging results when used as a prognostic tool early in the course of treatment of advanced Hodgkin lymphoma, allowing for a reduction in treatment for patients with favorable characteristics, while suggesting a benefit from changing therapy for those with a positive scan. For patients with limited disease, a negative scan allows for a decrease in treatment; however, the benefits for those patients whose scans are positive are less certain. Here we critically analyze the role of PET/CT in the early assessment of Hodgkin lymphoma. In Part 2, we will review the role of interim PET/CT in diffuse large B-cell lymphoma (DLBCL), and also explore the question of whether new approaches to quantitative assessment improve the prognostic value of interim PET scans in both Hodgkin lymphoma and DLBCL.

引用

页码：45 / 49

页数：5

共 50 条

[21] The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease
Evens, Andrew M.
Kostakoglu, Lale
BLOOD, 2014, 124 (23) : 3356 - 3364
[22] The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease
Evens, Andrew M.
Kostakoglu, Lale
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 135 - 143
[23] FDG-PET in the evaluation of lymphomas
Bodet-Milin, Caroline
Salaun, Pierre-Yves
Crespin, Celine
Vuillez, Jean-Philippe
Kraeber-Bodere, Francoise
HEMATOLOGIE, 2009, 15 (04): : 305 - 312
[24] FDG-PET for assessment of therapy in lymphoma patients
Mukhortova, O. V.
Bokeria, L. A.
Aslanidis, I. P.
Ekaeva, I. V.
Shavladze, Z. N.
Stroikovskii, D. L.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S292 - S292
[25] EVALUATION OF VISUAL AND SEMIQUANTITATIVE CRITERIA FOR RESPONSE FDG-PET INTERPRETATION IN PEDIATRIC HODGKIN LYMPHOMA
Kurch, L.
Mauz-Koerholz, C.
Koerholz, D.
Scuik, J.
Pfluger, T.
Schober, O.
Tchavdarova, L. I.
Sabri, O.
Kluge, R.
PEDIATRIC BLOOD & CANCER, 2011, 56 (05) : 881 - 882
[26] The role of FDG-PET in pediatric Non-Hodgkin lymphoma
Nakatani, K.
Nakamoto, Y.
Suga, T.
Miyake, K. K.
Kurihara, K.
Saga, T.
Higashi, T.
Togashi, K.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S434 - S434
[27] Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma
Kluge, R.
Koerholz, D.
KLINISCHE PADIATRIE, 2011, 223 (06): : 315 - 319
[28] Current Role of FDG-PET in Pediatric Hodgkin's Lymphoma
Kluge, Regine
Kurch, L.
Georgi, Thomas
Metzger, Monika
SEMINARS IN NUCLEAR MEDICINE, 2017, 47 (03) : 242 - 257
[29] Our FDG-PET experience in paediatric Hodgkin and non-Hodgkin lymphoma
Carena, M.
Cossalter, E.
Zecca, M.
Locatelli, F.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S204 - S204
[30] Role of FDG-PET/CT in Management of Hodgkin's Lymphoma
Gupta, Arun Kumar
Kandasamy, Devasenathipathy
Seth, Rachna
INDIAN JOURNAL OF PEDIATRICS, 2009, 76 (12): : 1273 - 1274

← 1 2 3 4 5 →